menu
    • menu

    Company profile for Tris Pharma Inc

    NEW Drugs in Dev: 7
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    REF. STANDARDS & IMPURITIES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Founded in 2000, Tris Pharma, Inc. is a technology driven, specialty pharmaceutical company. With our intense focus on application of physical chemistry in the biological systems, coupled with the requirements of manufacturing and market demands, we have built a successful track record in a relatively short time. Specifically, we are engaged in research, development, and manufacturing of both OTC and Rx branded products and sp...
    Founded in 2000, Tris Pharma, Inc. is a technology driven, specialty pharmaceutical company. With our intense focus on application of physical chemistry in the biological systems, coupled with the requirements of manufacturing and market demands, we have built a successful track record in a relatively short time. Specifically, we are engaged in research, development, and manufacturing of both OTC and Rx branded products and specialty generic products. Our mission is to understand the science driving the delivery of drugs into the human body; develop and bring to market products that add value to our customers and patients.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Tris Pharma IncUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Brunswick Business Park, 2033 Route 130, Suite D, Monmouth Junction, NJ 08852,
    Telephone
    Telephone
    (732) 940-2800
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.trispharma.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    BPI Europe

    BPI Europe

    Not Confirmed

    envelop Contact Supplier

    BPI Europe

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Tris Pharma Presents Encore Phase 3 Data On Acute Pain Treatment
    Tris Pharma Presents Encore Phase 3 Data On Acute Pain Treatment

    08 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/08/3269999/0/en/Tris-Pharma-to-Showcase-Encore-Phase-3-Data-Supporting-Continued-Progress-in-Acute-Pain-Treatment-at-ASRA-2026-Meeting-in-Phoenix.html

    GLOBENEWSWIRE
    08 Apr 2026
    Share Share
    Tris Pharma To Unveil Phase 3 Cebranopadol Data For Acute Pain
    Tris Pharma To Unveil Phase 3 Cebranopadol Data For Acute Pain

    26 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/26/3245472/0/en/Tris-Pharma-to-Present-Debut-Data-from-Phase-3-ALLEVIATE-1-2-Trials-Evaluating-Cebranopadol-in-Acute-Pain-at-AAPM-PainConnect-2026-Annual-Meeting.html

    GLOBENEWSWIRE
    26 Feb 2026
    Share Share
    Tris Pharma Spotlights Dual NOP-MOP Promise for Pain Treatment
    Tris Pharma Spotlights Dual NOP-MOP Promise for Pain Treatment

    08 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/08/3215386/0/en/Tris-Pharma-Announces-Acceptance-of-New-Publication-Highlighting-Promise-of-Dual-NOP-MOP-dual-NMR-Agonists-for-the-Treatment-of-Moderate-to-Severe-Pain.html

    GLOBENEWSWIRE
    08 Jan 2026
    Share Share
    Tris Pharma's NDA For Low-Sodium Oxybate In Narcolepsy Accepted
    Tris Pharma's NDA For Low-Sodium Oxybate In Narcolepsy Accepted

    09 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251209571909/en/Tris-Pharma-Announces-FDA-Acceptance-of-NDA-for-Once-Nightly-Low-Sodium-Oxybate-Product-for-Narcolepsy-and-Idiopathic-Hypersomnia

    BUSINESSWIRE
    09 Dec 2025
    Share Share
    Pfizer, Tris Settle ADHD Drug Claims With $41.5M In Texas
    Pfizer, Tris Settle ADHD Drug Claims With $41.5M In Texas

    20 Nov 2025

    // FIERCE PHARMA

    https://www.fiercepharma.com/pharma/pfizer-tris-pharma-ink-415m-deal-settle-adulterated-adhd-drug-allegations-texas

    FIERCE PHARMA
    20 Nov 2025
    Share Share
    Tris Pharma Publishes Review on Acute Pain Treatment Gaps
    Tris Pharma Publishes Review on Acute Pain Treatment Gaps

    16 Oct 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251016627732/en/Tris-Pharma-Announces-Acceptance-of-New-Review-Article-Highlighting-Challenges-of-Treating-Moderate-to-Severe-Acute-Pain-with-Currently-Available-Drugs

    BUSINESSWIRE
    16 Oct 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Contact Tris Pharma Inc and get a quotation

    Tris Pharma Inc is a supplier offers 6 products (APIs, Excipients or Intermediates).

    Find Carbinoxamine bulk with DMF offered by Tris Pharma Inc

    Find Chlorpheniramine Maleate bulk with DMF offered by Tris Pharma Inc

    Find Clonidine bulk with DMF offered by Tris Pharma Inc

    Find Codeine bulk with DMF offered by Tris Pharma Inc

    Find Methylphenidate bulk with DMF offered by Tris Pharma Inc

    Find Sodium Oxybate bulk with DMF offered by Tris Pharma Inc

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search